profit guy, OSTK when first mentioned looked hot indeed ... tight sucker with a big short if I recall. Many calls here don't get discussed much, which I think is a mistake. How do you think I felt when I was pounding the table on a recent biotech short after it ran through the roof based on weak findings and immediately discredited by some respected names.
Unfortunately, I left OSTK alone too though, even though it had the earmarks of a '99 style squeeze!